2015
DOI: 10.4149/neo_2015_035
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer

Abstract: Non-small cell lung cancer, positron emission tomography, multidetector computed tomography, metastases detection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…In recent decades, positron emission tomography (PET)/CT with fluorine-18-fludeoxyglucose ([ 18 F]FDG) has been extensively used in the preoperative setting for patients with lung cancer. This imaging approach is considered a key non-invasive staging method [ 16 ] and has shown better performance in LN staging (estimated sensitivity of 77% and specificity of 86%) compared to CT alone (55% and 81%, respectively) [ 17 , 18 , 19 ]. For PET imaging, the criterion for diagnosing LN involvement is the presence of LN uptake above the intensity of the surrounding background activity, with or without LN enlargement in co-registered CT imaging.…”
Section: Introductionmentioning
confidence: 99%
“…In recent decades, positron emission tomography (PET)/CT with fluorine-18-fludeoxyglucose ([ 18 F]FDG) has been extensively used in the preoperative setting for patients with lung cancer. This imaging approach is considered a key non-invasive staging method [ 16 ] and has shown better performance in LN staging (estimated sensitivity of 77% and specificity of 86%) compared to CT alone (55% and 81%, respectively) [ 17 , 18 , 19 ]. For PET imaging, the criterion for diagnosing LN involvement is the presence of LN uptake above the intensity of the surrounding background activity, with or without LN enlargement in co-registered CT imaging.…”
Section: Introductionmentioning
confidence: 99%
“…However, these methods have limited value in determining the nature of suspicious lung nodules, evaluating mediastinal involvement and also the tumor viability (4). Various radionuclide substances such as 67 Ga, 201Tl, and 99mTc-tetrofosmin, 99mTc-MIBI (technetium 99m hexakis 2-methoxy isobutyl isonitrile), and 18F-fluorodeoxyglucose are used in NSCLC staging, treatment response, and follow-up (4)(5)(6). The aim of this study is to evaluate the mediastinal lymph nodes (MLN) comparatively by using video-mediastinoscopy (VM), 99mTc-MIBI SPECT scintigraphy, and thoracic CT in the staging of NSCLC.…”
Section: Introductionmentioning
confidence: 99%